--2025/Q2-- / 9.146M--
--2025/Q1-- / 7.061M--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Taylor Morrison Home
TMHC
NVIDIA
NVDA
Adobe
ADBE
US Stock MarketDetailed Quotes
CTXR Citius Pharmaceuticals
- 3.9100
- +0.2300+6.25%
Close Dec 30 16:00 ET
- 3.9100
- 0.00000.00%
Pre 04:20 ET
30.21MMarket Cap-0.65P/E (TTM)
4.4000High3.4000Low378.13KVolume3.7500Open3.6800Pre Close1.49MTurnover4.96%Turnover RatioLossP/E (Static)7.73MShares26.750052wk High0.43P/B29.83MFloat Cap2.440052wk Low--Dividend TTM7.63MShs Float750.0000Historical High--Div YieldTTM27.17%Amplitude2.4400Historical Low3.9300Avg Price1Lot Size
Citius Pharmaceuticals Key Stats
Citius Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Citius Pharmaceuticals Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
